Indicators Of The Course Of Benign Prostatic Hyperplasia Depending On The Genotypes Of G2677t Mdr1 And T3435c Mdr1 Genes

Abstract

This paper presents the research results on the study of the features of clinical manifestations of benign prostatic hyperplasia and the effectiveness of its drug treatment, depending on the genotypes of the G2677T MDR1 and T3435C MDR1 genes. It was shown that there is a definite relationship between individual signs of the course of the disease and the carriage of genotypes of the studied genes. The effect of the treatment of the disease is also interrelated with the genotypes of the G2677T MDR1 and T3435C MDR1 genes.